Toluene
CAS 108-88-3
Toluene (CAS 108-88-3) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 25955.77 nM | 10 | - |
| - | IC50 | 2452.624 nM | 2 | - |
| - | Kd | 71000 nM | 1 | - |
| Acetylcholinesterase Enzyme |
IC50 | 8.28 | - | Homo sapiens |
| Endolysin Enzyme |
Kd | 4.15 | - | Enterobacteria phage T4 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Toluene used for in pharmaceutical contexts?
Toluene (CAS 108-88-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Toluene?
No adverse-event association or SIDER side-effect rows are rendered for Toluene in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Toluene also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Toluene Cosmetic with EU status "restricted".
What clinical phase is Toluene in?
Toluene is rendered with ChEMBL max phase 2.
What bioactivity targets are documented for Toluene?
Toluene has 5 bioactivity rows in this page query. Rendered target entries include Acetylcholinesterase, Endolysin.